Moneycontrol
HomeNewsBusinessStartupStimulus effect: Industry lobby writes to Sitharaman, wants startups included in MSMEs

Stimulus effect: Industry lobby writes to Sitharaman, wants startups included in MSMEs

The sector wants to be included in the financial package announced by the government.

May 14, 2020 / 17:10 IST
Story continues below Advertisement
File image

The Startup Association of India has requested Finance Minister Nirmala Sitharaman that startups be included in the micro, small and medium enterprises (MSMEs) category, which will allow them to benefit from the measures announced by the government for small businesses.

The minister had on May 13 shared the first details, with focus on MSMEs, of the Rs 20 lakh crore package Prime Minister Narendra Modi had announced a day earlier to give a boost to the economy ravaged by the coronavirus and the lockdown.

Story continues below Advertisement

“In the circumstances, startups (as defined by the DPIIT) should be allowed to come within the definition and ambit of an MSME,” association chairman Mahendra Swarup said in a letter to the minister.

Moneycontrol has seen a copy of the letter that was sent on May 14.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show